Personal tools

MCL coexpression mm9:692: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002193!1.33e-11!48;UBERON:0002405!1.33e-11!48;UBERON:0000077!4.17e-11!35;UBERON:0004177!7.55e-11!29;UBERON:0005057!7.55e-11!29;UBERON:0002390!2.05e-10!45;UBERON:0003061!2.05e-10!45;UBERON:0003408!1.59e-09!24;UBERON:0001004!2.06e-09!42;UBERON:0006562!3.10e-09!24;UBERON:0001557!3.10e-09!24;UBERON:0001042!3.10e-09!24;UBERON:0008814!3.10e-09!24;UBERON:0009145!3.10e-09!24;UBERON:0001041!4.43e-09!80;UBERON:0004119!4.59e-09!118;UBERON:0000925!4.59e-09!118;UBERON:0006595!4.59e-09!118;UBERON:0002370!4.64e-09!23;UBERON:0000974!4.64e-09!23;UBERON:0004807!4.64e-09!23;UBERON:0005058!4.64e-09!23;UBERON:0003351!4.64e-09!23;UBERON:0009113!4.64e-09!23;UBERON:0003295!4.64e-09!23;UBERON:0009722!4.64e-09!23;UBERON:0005562!4.64e-09!23;UBERON:0007690!4.64e-09!23;UBERON:0000065!5.53e-09!41;UBERON:0001007!6.56e-09!116;UBERON:0001555!6.56e-09!116;UBERON:0007026!6.56e-09!116;UBERON:0004921!2.06e-08!114;UBERON:0003081!2.04e-07!87;UBERON:0000926!3.51e-07!120;UBERON:0004120!3.51e-07!120;UBERON:0006603!3.51e-07!120
|ontology_enrichment_uberon=UBERON:0002193!1.33e-11!48;UBERON:0002405!1.33e-11!48;UBERON:0000077!4.17e-11!35;UBERON:0004177!7.55e-11!29;UBERON:0005057!7.55e-11!29;UBERON:0002390!2.05e-10!45;UBERON:0003061!2.05e-10!45;UBERON:0003408!1.59e-09!24;UBERON:0001004!2.06e-09!42;UBERON:0006562!3.10e-09!24;UBERON:0001557!3.10e-09!24;UBERON:0001042!3.10e-09!24;UBERON:0008814!3.10e-09!24;UBERON:0009145!3.10e-09!24;UBERON:0001041!4.43e-09!80;UBERON:0004119!4.59e-09!118;UBERON:0000925!4.59e-09!118;UBERON:0006595!4.59e-09!118;UBERON:0002370!4.64e-09!23;UBERON:0000974!4.64e-09!23;UBERON:0004807!4.64e-09!23;UBERON:0005058!4.64e-09!23;UBERON:0003351!4.64e-09!23;UBERON:0009113!4.64e-09!23;UBERON:0003295!4.64e-09!23;UBERON:0009722!4.64e-09!23;UBERON:0005562!4.64e-09!23;UBERON:0007690!4.64e-09!23;UBERON:0000065!5.53e-09!41;UBERON:0001007!6.56e-09!116;UBERON:0001555!6.56e-09!116;UBERON:0007026!6.56e-09!116;UBERON:0004921!2.06e-08!114;UBERON:0003081!2.04e-07!87;UBERON:0000926!3.51e-07!120;UBERON:0004120!3.51e-07!120;UBERON:0006603!3.51e-07!120
|tfbs_overrepresentation_for_novel_motifs=0.321524,1.23178,0.297937,0.360062,0.580303,0.975411,0.458558,0.124431,0.411053,0.255527,0.417132,1.13606,0.393382,0.470194,0.613681,0,0.656089,0.564478,0.113609,0.451901,1.34675,0.60924,0.469335,0.577226,0.304728,0.496413,0.709649,0.392919,0.67135,0.572447,0.379806,0.754912,0.191698,0.31333,0.214608,1.19266,0.184038,0.443753,0.166348,0.143746,0.572271,0.38461,0.307718,0.215898,0.0422997,0.349801,0.578773,0.407653,0.255625,0.241306,0.639101,0.522137,0.550735,0.894161,0.911367,0.47699,0.695271,0.435119,0.332535,0.47505,0.735292,0.531188,0.433822,0.628155,0.487593,0.667546,1.04613,1.3932,0.730718,1.24673,0.281085,0.128829,0.155003,0.944464,0.659328,0.300089,0.646602,0.567793,0.718494,0.268962,0.406536,0.673009,0.529804,1.24891,0.830765,0.0593483,0.182066,0.572901,0.583509,1.55487,1.11522,0.835661,0.767462,0.592123,3.68571,0.892226,0.388243,0.770215,0.57902,0.234357,0.184103,0.754637,0.87698,0.639679,0.638654,0.3842,0.696857,0.403887,0.273261,0.266818,0.315128,0.878738,0.743427,0.421988,1.12221,0.5687,0.212667,0.363536,0.657356,0.181004,0.949798,0.607824,0.498153,0.566919,1.17594,0.722111,0.466292,0.760818,1.04463,0.207624,0.86025,0.353344,1.01535,0.48999,1.14365,0.0358067,0.329172,0.385921,1.09487,1.92247,1.5231,1.0508,0.509663,0.765172,0.632358,1.77315,0.581788,1.88287,0.331322,0.201635,1.46048,0.129005,0.895708,0.153911,0.489108,0.976367,0.523103,0.637798,0.319291,0.328917,1.1043,0.829923,0.722546,0.313083,0.629147,0.482049,0.53929,0.445669,0.0054279
}}
}}

Revision as of 18:45, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:79481586..79481606,-p@chr10:79481586..79481606
-
Mm9::chr13:41582719..41582736,-p3@Nedd9
Mm9::chr13:67433461..67433489,-p2@Zfp595
Mm9::chr17:32661006..32661031,-p@chr17:32661006..32661031
-
Mm9::chr17:71274298..71274343,-p1@ENSMUST00000142133
p1@uc008dlt.1
Mm9::chr2:43832143..43832147,+p@chr2:43832143..43832147
+
Mm9::chr3:106524816..106524872,+p1@4933421E11Rik
Mm9::chr4:154998686..154998743,-p1@ENSMUST00000154931
Mm9::chr5:110487031..110487072,-p@chr5:110487031..110487072
-
Mm9::chr8:23812002..23812051,-p@chr8:23812002..23812051
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
lymphoid lineage restricted progenitor cell8.09e-0712

Uber Anatomy
Ontology termp-valuen
hemolymphoid system1.33e-1148
immune system1.33e-1148
mixed endoderm/mesoderm-derived structure4.17e-1135
hemopoietic organ7.55e-1129
immune organ7.55e-1129
hematopoietic system2.05e-1045
blood island2.05e-1045
gland of gut1.59e-0924
respiratory system2.06e-0942
pharynx3.10e-0924
upper respiratory tract3.10e-0924
chordate pharynx3.10e-0924
pharyngeal arch system3.10e-0924
pharyngeal region of foregut3.10e-0924
foregut4.43e-0980
endoderm-derived structure4.59e-09118
endoderm4.59e-09118
presumptive endoderm4.59e-09118
thymus4.64e-0923
neck4.64e-0923
respiratory system epithelium4.64e-0923
hemolymphoid system gland4.64e-0923
pharyngeal epithelium4.64e-0923
thymic region4.64e-0923
pharyngeal gland4.64e-0923
entire pharyngeal arch endoderm4.64e-0923
thymus primordium4.64e-0923
early pharyngeal endoderm4.64e-0923
respiratory tract5.53e-0941
digestive system6.56e-09116
digestive tract6.56e-09116
primitive gut6.56e-09116
subdivision of digestive tract2.06e-08114
lateral plate mesoderm2.04e-0787
mesoderm3.51e-07120
mesoderm-derived structure3.51e-07120
presumptive mesoderm3.51e-07120


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}